Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Adam5 (ADAM metallopeptidase domain 5) Rattus norvegicus
Analyze
Symbol: Adam5
Name: ADAM metallopeptidase domain 5
Description: Predicted to have metalloendopeptidase activity. Involved in male gonad development. Predicted to localize to the integral component of membrane. Orthologous to human ADAM5 (ADAM metallopeptidase domain 5 (pseudogene)); INTERACTS WITH acrylamide; ammonium chloride; bisphenol A.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: a disintegrin and metallopeptidase domain 5; a disintegrin and metalloprotease domain (ADAM) 5; a disintegrin and metalloprotease domain 5; disintegrin and metalloproteinase domain-containing protein 5; MGC108772; tMDC II; tMDCII; transmembrane metalloproteinase-like, disintegrin-like, and cysteine-rich protein II
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.01672,010,069 - 72,085,666 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01671,658,527 - 71,732,482 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41671,652,550 - 71,720,886 (+)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.11671,661,011 - 71,685,667 (+)NCBI
Celera1665,125,575 - 65,192,645 (+)NCBICelera
Cytogenetic Map16q12.4NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on Adam5
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 621471
Created: 2002-08-06
Species: Rattus norvegicus
Last Modified: 2019-08-20
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.